Zolacabtagene Autoleucel
Chemical
FDA Substance Registry (openFDA)
Chemical Identification
Known Aliases (4)
Common Name
BMS-986353
BMS-986353 is an investigational CD19-targeted CAR T-cell product. The CD19-specific CAR consists of a single-chain variable fragment (scFv) binding domain derived from a CD19-specific monoclonal antibody (mAb; FMC63), an IgG-derived hinge region, a CD28 transmembrane domain, and the CD137 (41BB) and CD3ζ chain signaling domains. The third-generation SIN lentiviral vector, which encodes the CAR domains described above, also encodes a truncated human epidermal growth factor receptor (EGFRt) that is expressed separately from the CD19 CAR on the T cell surface
CC-97540
ZOLACABTAGENE AUTOLEUCEL [USAN]
Data Sources (1)
| Source | Source ID | Name in Source | Properties |
|---|---|---|---|
| FDA Substance Registry (openFDA) | DU963TX85S |
Zolacabtagene Autoleucel |
INN: 13483 USAN: MN-86 SMS_ID: 300000050484 FDA UNII: DU963TX85S NCI_THESAURUS: C175049 |
Record Info
| ID | MuuaEGHVn9fs7VVBAWDKtq |
|---|---|
| Created | April 10, 2026, 8:33 p.m. |
| Modified | April 11, 2026, 12:35 a.m. |
| Data Source | FDA Substance Registry (openFDA) |